Safety Info

Important Safety Information
Full Prescribing Information

Important Safety Information,
including BOXED WARNING
Full Prescribing Information

Important Safety Information,
including BOXED WARNING
Full Prescribing Information

Important Safety Information
Full Prescribing Information

<Variable Practice Name> Account Menu

Settings Log Out

Continue

Click for RINVOQ/RINVOQ LQ Important Safety Information, including BOXED WARNING on Serious Infections, Mortality, Malignancies, Major Adverse Cardiovascular Events, and Thrombosis.

Click for HUMIRA Important Safety Information, including BOXED WARNING on Serious Infections and Malignancy.

Click for SKYRIZI Important Safety Information.

Full prescribing information for RINVOQ/RINVOQ LQ, HUMIRA, and SKYRIZI.

Privacy Notice | Cookie Settings | Your Privacy Choices

US-MULT-240326 | ©AbbVie 2024. Patent Pending. | Contact Us | Accessibility Statement

Contact Us

Technical Support

877-COMPLETE (877-266-7538) Option 3

(Monday through Friday from 7:00 A.M. to 7:00 P.M. Central Time)

AbbVie Access Support

877-COMPLETE (877-266-7538) Option 2

(Monday through Friday from 7:00 A.M. to 7:00 P.M. Central Time)

myAbbVie Assist Patient Assistance

Phone: 800-222-6885

Fax: 866-250-2803

Customer Solutions Specialist

Field Access Specialist

US-MULT-240326